# Proceedings from the 2023 transdisciplinary conference for future leaders in precision public health “Applying Implementation Science to Precision Public Health”

**Authors:** Katherine W. Saylor, Caitlin G. Allen, Jarrod Marable, Cason Whitcomb, Dana Lee Olstad, Julia Steinberg, Amelia Smit, Erin Turbitt, Kimberly Foss, Latrice Landry, Megan C. Roberts

PMC · DOI: 10.1186/s12919-025-00332-6 · BMC Proceedings · 2025-07-03

## TL;DR

This paper summarizes a 2023 conference on integrating implementation science into precision public health to improve real-world application and sustainability.

## Contribution

The paper highlights key implementation needs and strategies for advancing precision public health through transdisciplinary collaboration.

## Key findings

- Key implementation needs include evidence of clinical utility and feasibility.
- Context-specific factors and user engagement are critical for successful PPH programs.
- A workshop generated ideas for essential outcomes and health equity strategies in PPH.

## Abstract

Precision public health (PPH) approaches use big data to inform tailored, population-level interventions. The field has roots in genomics, but it has expanded to encompass data-informed public health programs across various types of data or applications. The Precision Public Health Network hosted a 2023 conference focused on implementation science—the study of how to integrate PPH programs into practice. Some implementation needs that emerged across speakers included establishing robust evidence of clinical utility and feasibility, disseminating clinical best practices through guidelines and tools for providers, sharing tools or information to reduce duplicated efforts across settings, and considering context-specific factors. Considering feasibility, setting-specific factors, and meaningful engagement with relevant user groups throughout the research and implementation process are critical to the successful and sustainable implementation of PPH programs. The Network also hosted an interactive workshop to generate ideas and ongoing collaboration on essential outcomes or data measures for PPH programs, and strategies to center health equity in PPH. This conference and workshop are part of the ongoing work of the PPHN to convene experts across disciplines and settings, share knowledge, and galvanize the field of PPH.

## Full-text entities

- **Genes:** BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}
- **Diseases:** Hereditary Breast and Ovarian Cancer (MESH:D061325), cancer (MESH:D009369), PPH (MESH:C000719203), dementia (MESH:D003704), anxiety (MESH:D001007), Undiagnosed Disease (MESH:D000080842), Hereditary Cancer (MESH:D009386), diabetes (MESH:D003920), breast cancer (MESH:D001943), knee osteoarthritis (MESH:D020370), Lynch Syndrome (MESH:D003123), Rare Disease (MESH:D035583), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12224343/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12224343/full.md

---
Source: https://tomesphere.com/paper/PMC12224343